Jain Global’s Niagen Bioscience NAGE Stock Holding History

Jain Global’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-40,500	Closed	-$584K	–	1612
2025 Q2	$584K	Buy	+40,500	New	+$400K	﹤0.01%	763

Other funds holding NAGE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jain Global's NAGE Position: Q3 2025 in Review

Jain Global sold out of Niagen Bioscience (NAGE) in Q3 2025, closing a stake of 40,500 shares — an estimated $584K sold.

Jain Global first reported a position in NAGE in Q2 2025 and held it in 1 quarter. The position peaked at $584K in Q2 2025. 162 funds tracked by Wall St. Rank hold NAGE as of Q3 2025.

Jain Global reported no remaining Niagen Bioscience position as of Q3 2025 after selling out during the quarter.
Jain Global sold 40,500 Niagen Bioscience shares in Q3 2025, an estimated $584K.
Jain Global first reported a position in Niagen Bioscience in Q2 2025 and held it in 1 quarter.
Jain Global's Niagen Bioscience position peaked at $584K in Q2 2025.
162 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2025.

Based on Jain Global's 13F filing for Q3 2025, filed 14 Nov 2025.